Shareholders and creditors approve NCLT scheme with Meridian Medical Research
NH · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 3.1 pts less than Nifty Smallcap 250 and 1.6 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Meetings of equity shareholders, secured creditors, unsecured loan creditors and unsecured trade creditors were held on January 19, 2026 as directed by NCLT Bengaluru. All groups approved the scheme of arrangement between Meridian Medical Research and Hospital Ltd (transferor) and Narayana Hrudayalaya (transferee). Equity shareholders voted 99.99 percent in favor, with about 16.23 crore shares in favor. All creditor groups voted 100 percent in favor. The scheme now awaits final NCLT sanction.
Scheme advances toward NCLT final approval. If sanctioned, Meridian Medical Research will merge into Narayana Hrudayalaya, expanding its hospital network.